Clinical Trial Update: Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating semaglutide for metabolic abnormalities and fertility improvements in obese infertile women with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Peking University First Hospital | Conditions: PCOS (Polycystic Ovary Syndrome), Semaglutide | Phase 4 | Status: UNKNOWN